(Q38323461)

2 September 2017

1 reference

title

Functional significance of aberrantly expressed microRNAs in prostate cancer (English)

1 reference

2 September 2017

1 reference

1 reference

3

Hideki Enokida

1 reference

2 September 2017

5

Naohiko Seki

1 reference

2 September 2017

Yusuke Goto

1

1 reference

2 September 2017

Akira Kurozumi

series ordinal

2

1 reference

2 September 2017

Tomohiko Ichikawa

series ordinal

4

1 reference

2 September 2017

publication date

20 January 2015

1 reference

International Journal of Urology

2 September 2017

published in

1 reference

2 September 2017

volume

22

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

242-252

1 reference

2 September 2017

cites work

Cancer statistics, 2013

1 reference

International variation in prostate cancer incidence and mortality rates.

21 January 2018

1 reference

Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.

21 January 2018

1 reference

Landscape of transcription in human cells

21 January 2018

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

21 January 2018

1 reference

Most mammalian mRNAs are conserved targets of microRNAs

21 January 2018

1 reference

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

Aberrant regulation and function of microRNAs in cancer.

21 January 2018

1 reference

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

21 January 2018

1 reference

21 January 2018

1 reference

MicroRNA and drug resistance

21 January 2018

1 reference

MicroRNA and cancer: Current status and prospective

21 January 2018

1 reference

MicroRNAs and cancer: past, present, and potential future

21 January 2018

1 reference

MicroRNA signatures in human cancers

21 January 2018

1 reference

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

21 January 2018

1 reference

Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR

21 January 2018

1 reference

Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.

21 January 2018

1 reference

MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening

21 January 2018

1 reference

A miRNA expression signature that separates between normal and malignant prostate tissues.

21 January 2018

1 reference

The microRNA profile of prostate carcinoma obtained by deep sequencing

21 January 2018

1 reference

MicroRNA expression profiling in prostate cancer

21 January 2018

1 reference

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

21 January 2018

1 reference

The mutational landscape of prostate cancer

21 January 2018

1 reference

Prevalent mutations in prostate cancer

21 January 2018

1 reference

Genome-wide screening for genetic changes in a matched pair of benign and prostate cancer cell lines using array CGH.

21 January 2018

1 reference

High resolution oligonucleotide CGH using DNA from archived prostate tissue

21 January 2018

1 reference

Genetic changes in pT2 and pT3 prostate cancer detected by comparative genomic hybridization

21 January 2018

1 reference

High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer

21 January 2018

1 reference

A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain

21 January 2018

1 reference

Origin, evolution, and biological role of miRNA cluster in DLK-DIO3 genomic region in placental mammals

21 January 2018

1 reference

Genomic imprinting at the mammalian Dlk1-Dio3 domain

21 January 2018

1 reference

Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor

21 January 2018

1 reference

MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells.

21 January 2018

1 reference

Genome-wide analysis reveals downregulation of miR-379/miR-656 cluster in human cancers

21 January 2018

1 reference

Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases

21 January 2018

1 reference

microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers

21 January 2018

1 reference

Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma

21 January 2018

1 reference

The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer

21 January 2018

1 reference

miR-21 as a key regulator of oncogenic processes

21 January 2018

1 reference

MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3).

21 January 2018

1 reference

miR-21: an oncomir on strike in prostate cancer.

21 January 2018

1 reference

MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways

21 January 2018

1 reference

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

21 January 2018

1 reference

HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma

21 January 2018

1 reference

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c

21 January 2018

1 reference

MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1

21 January 2018

1 reference

Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma

21 January 2018

1 reference

miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4.

21 January 2018

1 reference

Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma

21 January 2018

1 reference

Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers

21 January 2018

1 reference

Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells

21 January 2018

1 reference

Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity.

21 January 2018

1 reference

Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.

21 January 2018

1 reference

Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease

21 January 2018

1 reference

Changes in circulating microRNA levels associated with prostate cancer

21 January 2018

1 reference

Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer

21 January 2018

1 reference

Snail-regulated MiR-375 inhibits migration and invasion of gastric cancer cells by targeting JAK2.

21 January 2018

1 reference

miR-375 inhibits Helicobacter pylori-induced gastric carcinogenesis by blocking JAK2-STAT3 signaling

21 January 2018

1 reference

Significance of dysregulated metadherin and microRNA-375 in head and neck cancer.

21 January 2018

1 reference

E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer

21 January 2018

1 reference

Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling

21 January 2018

1 reference

Epidermal growth factor receptor potentiates MCM7-mediated DNA replication through tyrosine phosphorylation of Lyn kinase in human cancers

21 January 2018

1 reference

Identification of a novel tumor transforming gene GAEC1 at 7q22 which encodes a nuclear protein and is frequently amplified and overexpressed in esophageal squamous cell carcinoma

21 January 2018

1 reference

Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer

21 January 2018

1 reference

Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis

21 January 2018

1 reference

MCM7 amplification and overexpression are associated with prostate cancer progression

21 January 2018

1 reference

Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation

21 January 2018

1 reference

Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters

21 January 2018

1 reference

MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer.

21 January 2018

1 reference

The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer

21 January 2018

1 reference

Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer

21 January 2018

1 reference

Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer

21 January 2018

1 reference

Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer

21 January 2018

1 reference

MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A.

21 January 2018

1 reference

miR221/222 in cancer: their role in tumor progression and response to therapy

21 January 2018

1 reference

miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer

21 January 2018

1 reference

MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer

21 January 2018

1 reference

MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer

21 January 2018

1 reference

Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3.

21 January 2018

1 reference

Aberrant expression of microRNAs in bladder cancer

21 January 2018

1 reference

Modulation of microRNA processing by p53

21 January 2018

1 reference

p53 represses c-Myc through induction of the tumor suppressor miR-145

21 January 2018

1 reference

Complementation by wild-type p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression

21 January 2018

1 reference

p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest

21 January 2018

1 reference

PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC.

21 January 2018

1 reference

c-Myc-regulated microRNAs modulate E2F1 expression

21 January 2018

1 reference

The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression

21 January 2018

1 reference

The functional significance of miR-1 and miR-133a in renal cell carcinoma

21 January 2018

1 reference

Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells

21 January 2018

1 reference

Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer

21 January 2018

1 reference

The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells

21 January 2018

1 reference

The microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin

21 January 2018

1 reference

The role of microRNA in castration-resistant prostate cancer

21 January 2018

1 reference

miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients

21 January 2018

1 reference

MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells

21 January 2018

1 reference

Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells

21 January 2018

1 reference

Roles of microRNAs during prostatic tumorigenesis and tumor progression

21 January 2018

1 reference

miR-21 as an independent biochemical recurrence predictor and potential therapeutic target for prostate cancer

21 January 2018

1 reference

Biochemical relapse following radical prostatectomy and miR-200a levels in prostate cancer

21 January 2018

1 reference

The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients

21 January 2018

1 reference

Identification of miR-30d as a novel prognostic maker of prostate cancer

21 January 2018

1 reference

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology

21 January 2018

1 reference

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection

21 January 2018

1 reference

Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients

21 January 2018

1 reference

Circulating microRNAs (miRNA) in serum of patients with prostate cancer

21 January 2018

1 reference

MicroRNAs and prostate cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/IJU.12700

1 reference

2 September 2017

1 reference